Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery
Authors:
- C. BofillCBC. Bofill
- J. JovenJ. Joven
- X. ClivilléXCX. Clivillé
- J.M. SimóJSJ.M. Simó
- X. LlobetXLX. Llobet
- A. PeróAPA. Peró
- J. GalbanyJGJ. Galbany
- 1 September 1996
- journal article
- clinical trial
- Published by Wiley in Transfusion
- Vol. 36 (9) , 822-826
Abstract
Background: Clinical and pharmacokinetic data suggest that very low doses of subcutaneous recombinant human erythropoietin (rHuEPO) may be effective in a preoperative autologous blood deposit program. Study Design and Methods: Fifty‐two patients, scheduled for orthopedic surgery, were enrolled in a double‐blind and placebo‐controlled study. Patients were randomly assigned to the placebo group or to receive 30, 60, or 100 IU per kg of rHuEPO subcutaneously twice a week for 2 weeks before surgery. The dose of rHuEPO that was effective in facilitating the collection of 4 units of blood in the 2 weeks before surgery and that prevented a sharp decrease in hematocrit was determined. Results: Only in patients receiving 100 IU per kg of rHuEPO did the outcome measurements differ significantly from those in the placebo group. With a higher (p < 0.01) cumulative increase in red cell volume during the study period (297 ± 127 vs. 121 ± 44 mL), 64 percent of those receiving 100 IU per kg of rHuEPO were able to donate 4 units of blood for autologous use, as compared with 23 percent of the placebo group (p < 0.05). Allogeneic transfusion was avoided, and the preoperative hematocrit and reticulocyte count were significantly higher in the patients receiving 100 IU per kg of rHuEPO (p < 0.05 and p < 0.01, respectively). Conclusion: Subcutaneously administered rHuEPO at a dose of 100 IU per kg twice a week for 2 weeks is effective in facilitating the collection of blood for autologous use and may improve the cost‐benefit ratio of blood conservation interventions. Doses ≤ 60 IU per kg are ineffective in facilitating such collections in this surgical setting.Keywords
This publication has 23 references indexed in Scilit:
- Prudent Strategies for Elective Red Blood Cell TransfusionAnnals of Internal Medicine, 1992
- The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.British Journal of Clinical Pharmacology, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Limitations to Donating Adequate Autologous Blood Prior to Elective Orthopedic SurgeryArchives of Surgery, 1989
- Methods for Measuring Erythropoietin and Erythropoietin Antibodies Using ELISA Technique1989
- Experience with Daily Self-Administered Subcutaneous Erythropoietin1989
- Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV AntibodyNew England Journal of Medicine, 1988
- Autologous Blood Donation for Elective SurgeryJAMA, 1987
- Utilization and effectiveness of a hospital autologous preoperative blood donor programTransfusion, 1986